Ni Zhen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
Papers in
-
- RNA Research and Splicing 5
- DNA Repair Mechanisms 4
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Co-authors
- Fenyong Sun (7 shared papers)Qiuhui Pan (8 shared papers)Ji Ma (5 shared papers)Jiabei Zhu (6 shared papers)Nan Huang (5 shared papers)Guo‐Qing Zhu (4 shared papers)Qingyuan Yang (4 shared papers)Lei Jin (2 shared papers)
In The Last Decade
Ni Zhen
17 papers receiving 432 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 202
- Molecular Biology 317
- Cell Biology 56
- Pulmonary and Respiratory Medicine 79
- Biochemistry 16
Countries citing papers authored by Ni Zhen
This map shows the geographic impact of Ni Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni Zhen more than expected).
Fields of papers citing papers by Ni Zhen
This network shows the impact of papers produced by Ni Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni Zhen. The network helps show where Ni Zhen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ni Zhen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 102 | |
| 2 | 2021 | 94 | |
| 3 | 2019 | 63 | |
| 4 | 2016 | 38 | |
| 5 | 2015 | 20 | |
| 6 | 2020 | 20 | |
| 7 | 2022 | 13 | |
| 8 | 2009 | 12 | |
| 9 | 2016 | 12 | |
| 10 | 2018 | 11 | |
| 11 | 2016 | 11 | |
| 12 | 2016 | 9 | |
| 13 | 2023 | 9 | |
| 14 | 2017 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2025 | 3 | |
| 17 | 2004 | 3 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2023 | 0 |
About Ni Zhen
Ni Zhen is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Cell Biology and Oncology, having authored 20 papers that have together received 435 indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), Cancer-related molecular mechanisms research (5 papers), DNA Repair Mechanisms (4 papers), MicroRNA in disease regulation (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers), RNA modifications and cancer (3 papers), Autophagy in Disease and Therapy (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (202 citations), Molecular Biology (317 citations), Cell Biology (56 citations), Pulmonary and Respiratory Medicine (79 citations) and Biochemistry (16 citations). Ni Zhen has collaborated with scholars based in China, Macao and Slovenia. Frequent co-authors include Fenyong Sun, Qiuhui Pan, Ji Ma, Jiabei Zhu, Nan Huang, Guo‐Qing Zhu, Qingyuan Yang, Lei Jin, Zhixuan Bian and Miao Ding. Their work appears in journals such as Cell Death Discovery, Tumor Biology, The International Journal of Biochemistry & Cell Biology, Nature Communications and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.